Aristidis Moustakas Selected Research

serglycin

5/2020	Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential.
12/2018	Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
1/2013	Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aristidis Moustakas Research Topics

Disease

48	Neoplasms (Cancer) 01/2022 - 06/2002
15	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2009
14	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2006
8	Carcinoma (Carcinomatosis) 01/2019 - 07/2006
5	Carcinogenesis 11/2021 - 06/2002
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2018
2	Brain Neoplasms (Brain Tumor) 05/2020 - 06/2015
2	Triple Negative Breast Neoplasms 10/2018 - 01/2018
2	Infections 03/2013 - 02/2003
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Hyperplasia 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Starvation 01/2021
1	Liver Neoplasms (Liver Cancer) 05/2019
1	Hepatocellular Carcinoma (Hepatoma) 05/2019
1	Fibrosis (Cirrhosis) 04/2018
1	Glioma (Gliomas) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Adenocarcinoma 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Pathologic Processes 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Skin Neoplasms (Skin Cancer) 01/2016
1	Pathologic Neovascularization 10/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011

Drug/Important Bio-Agent (IBA)

11	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 07/2012
10	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2003
7	Transforming Growth Factor beta (TGF-beta)IBA 04/2018 - 06/2002
6	Transcription Factors (Transcription Factor)IBA 11/2019 - 07/2006
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
5	Phosphotransferases (Kinase)IBA 01/2022 - 01/2011
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
4	Epidermal Growth Factor (EGF)IBA 01/2020 - 02/2011
3	Cadherins (E-Cadherin)IBA 01/2022 - 08/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2012
3	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2021 - 06/2015
3	serglycinIBA 05/2020 - 01/2013
3	ChromatinIBA 01/2019 - 03/2013
3	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 06/2005
3	CytokinesIBA 11/2018 - 08/2014
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2016
2	NestinIBA 01/2022 - 10/2021
2	RNA (Ribonucleic Acid)IBA 11/2021 - 07/2015
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2019
2	Fibronectins (Fibronectin)IBA 05/2019 - 01/2017
2	Hyaluronan SynthasesIBA 01/2019 - 08/2014
2	Biological ProductsIBA 02/2016 - 01/2016
2	UbiquitinIBA 09/2013 - 06/2005
2	Ligases (Synthetase)IBA 09/2013 - 06/2005
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Red Fluorescent ProteinIBA 01/2022
1	Platelet-Derived Growth FactorIBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Cytostatic AgentsIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	CollagenIBA 11/2019
1	Liver X ReceptorsIBA 05/2019
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 05/2019
1	T0901317IBA 05/2019
1	CalponinsIBA 05/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019
1	Antisense RNA (Anti-Sense RNA)IBA 01/2019
1	Estrogen ReceptorsIBA 12/2018
1	Interleukin-8 (Interleukin 8)IBA 12/2018
1	Proteoglycans (Proteoglycan)IBA 12/2018
1	ChemokinesIBA 12/2018
1	Zinc Finger E-box-Binding Homeobox 1IBA 10/2018
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	LipidsIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	heparanaseIBA 03/2017
1	EphrinsIBA 01/2017
1	Eph Family Receptors (Eph Receptors)IBA 01/2017
1	Ephrin-B1 (Ephrin B1)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 05/2016
1	VanadiumIBA 05/2016
1	LigandsIBA 02/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Cyclin-Dependent Kinase 4IBA 01/2016
1	Tamoxifen FDA LinkGeneric 12/2015
1	Hormones (Hormone)IBA 04/2015
1	Estrogen Receptor alphaIBA 04/2015
1	GlycosaminoglycansIBA 08/2014
1	PlasticsIBA 08/2014
1	histidine-rich proteinsIBA 10/2013
1	TNF Receptor-Associated Factor 4IBA 09/2013
1	Complement System Proteins (Complement)IBA 01/2013
1	MicroRNAs (MicroRNA)IBA 10/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2012
1	trimethyloxamine (trimethylamine N-oxide)IBA 03/2009

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2011
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 05/2016